Nrx pharmaceuticals, lotus pharmaceuticals and alvogen inc. announce collaboration to develop and commercialize nrx-101

Radnor, pa. and morristown, n.j. and taipei, taiwan, june 05, 2023 (globe newswire) -- lotus pharmaceuticals (1795:tt; “lotus”), a multinational pharmaceutical company, alvogen, a privately owned u.s. based pharmaceuticals company, and nrx pharmaceuticals inc. (nasdaq: nrxp) (“nrx pharmaceuticals or nrx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of nrx-101 for suicidal treatment-resistant bipolar depression (s-trbd) for global markets.
NRXP Ratings Summary
NRXP Quant Ranking